06/02/2026
As the American Society of Clinical Oncology (ASCO) Annual Meeting comes to a close, we’re reflecting on an inspiring week of discovery, collaboration, and progress in cancer research.
Throughout the meeting, our faculty, trainees, and research teams shared innovative findings and clinical trial updates across a wide range of cancer types. From studies exploring how physician diversity impacts access to cancer care, to advances in lung, breast, ovarian, kidney, head and neck, and blood cancers, our teams were proud to contribute to conversations that are helping shape the future of oncology.
Highlights also included research on the use of artificial intelligence in cancer diagnosis and treatment, emerging immunotherapy approaches, new insights into treatment resistance, and promising clinical trial results that may help improve outcomes for patients.
We were also delighted to host our annual ASCO reception, bringing together faculty, fellows, alumni, colleagues, and friends for an evening of connection and celebration. Events like these remind us that progress in cancer care is driven not only by scientific discovery, but also by the partnerships and community that make that work possible.
We are incredibly proud of our faculty, trainees, investigators, and research teams for their dedication and contributions, making such a productive and inspiring meeting.
https://medicine.yale.edu/news-article/yale-cancer-center-researchers-and-trainees-present-at-2026-asco-annual-meeting/